UNC Lineberger’s Hazel Nichols, PhD, and collaborators from the Premenopausal Breast Cancer Collaborative Group identified elevated breast cancer risk after childbirth in women younger than 55.
Younger women who have recently had a child may have a higher risk of breast cancer than their peers of the same age who do not have children, according to a large-scale analysis co-led by a University of North Carolina Lineberger Comprehensive Cancer Center researcher.
The findings, published in the Annals of Internal Medicine, may seem contrary to conventional wisdom that childbirth is protective against breast cancer. Researchers say childbirth still does become protective, but it can take more than two decades for benefits to emerge. Breast cancer is more common in older women, with the median age of 62 at diagnosis in the United States. Researchers who led the study from the Premenopausal Breast Cancer Collaborative Group identified elevated breast cancer risk after childbirth in women younger than 55.
“What most people know is that women who have children tend to have lower breast cancer risk than women who have not had children, but that really comes from what breast cancer looks like for women in their 60s and beyond,” said UNC Lineberger’s Hazel B. Nichols, PhD, an assistant professor in the UNC Gillings School of Global Public Health Department of Epidemiology. “We found that it can take more than 20 years for childbirth to become protective for breast cancer, and that before that, breast cancer risk was higher in women who had recently had a child.”
Other studies have shown an increase in breast cancer risk in younger women after childbirth, but have not had access to information about other factors that might impact risk, such as breastfeeding or family history of breast cancer, researchers said. For their analysis, researchers pooled data from 15 prospective studies from the around the globe that included 889,944 women. In addition to looking at breast cancer risk after childbirth, they also evaluated the impact of other factors, such as breastfeeding and a family history of breast cancer.
They found that, in women 55 years and younger, breast cancer risk peaked about five years after they gave birth, with risk for mothers 80 percent higher compared with women who did not give birth. Twenty-three years after giving birth, women saw their risk level off, and pregnancy started to become protective. The increased risk after childbirth was higher for women who also had a family history of breast cancer or who had a greater number of births or were older at first birth. The pattern looked the same whether or not women breastfed.
“We need to recognize that the traditional risk factors for breast cancer do not always operate the same way at younger ages,” Nichols said.
While breast cancer risk increased for mothers after pregnancy, researchers also noted that the overall risk of breast cancer is still low in this group. Between the ages of 41 and 45, there were 41 more cases of breast cancer diagnosed in every 100,000 women who had given birth in the previous three to seven years compared with women who did not have children. By age 50, there were 247 more cases per 100,000 women in the group that had recently given birth.
“In this age group, breast cancer is uncommon,” Nichols said. “The risk of developing breast cancer is still low overall, even if you’ve had a child five years ago.”
Their findings were also not the same for all younger women. Risk was higher for women who had their first child after 35, but there was no increased risk of breast cancer after a recent birth for women who had their first child before 25. And while pregnancy did become protective against estrogen receptor-positive breast cancer years later, it did not become protective for estrogen-receptor negative breast cancer during the study.
“This is evidence of the fact that just as breast cancer risk factors for young women can differ from risk factors in older women, there are different types of breast cancer, and the risk factors for developing one type versus another can differ,” Nichols said.
The study’s findings could be used to develop better breast cancer risk prediction models to help inform screening decisions and prevention strategies, Nichols said.
“There are many ongoing studies that are trying to improve our ability to do breast cancer risk prediction on the individual level,” Nichols said. “This is one piece of evidence that can be considered for building new prediction models.”
In addition, the study could lead to greater breast cancer awareness among young mothers and medical providers.
“We want women and their doctors to not assume that recently having a child is always protective for breast cancer,” Nichols said.
In addition to Nichols, Dale Sandler, PhD, a senior investigator with the National Institute of Environmental Health Sciences, Minouk K. Schoemaker, PhD, staff epidemiologist with The Institute of Cancer Research in London and Anthony J. Swerdlow, DM, DSc, of The Institute of Cancer Research in London, led the study. Other authors included; Jianwen Cai, PhD, and Jiawei Xu, BS, of the UNC Gillings School of Global Public Health; Lauren B. Wright, MSc, Mark N. Brook, PhD, and Michael E. Jones, PhD, of The Institute of Cancer Research, London; Hans-Olov Adami, MD, PhD, of the Karolinska Institutet in Stockholm, Sweden; Laura Baglietto, PhD, of the University of Pisa Department of Clinical and Experimental Medicine; Kimberly A. Bertrand, ScD, and Julie R. Palmer, ScD, of the Slone Epidemiology Center at Boston University; William J. Blot, PhD, and Wei Zheng, MD, PhD of the Vanderbilt-Ingram Cancer Center; Marie-Christine Boutron-Ruault, MD, PhD, of Inserm U1018, Institute Gustave Roussy, CESP and University Paris-Saclay, University of Paris-Sud, Villejuif, France; Miren Dorronsoro, MD, of the Public Health Direction and Biodonostia Research Institute and Ciberesp, Basque Regional Health Department, Spain; Laure Dossus, PhD, of the International Agency for Research on Cancer, France: A. Heather Eliassen, ScD, and Rulla M. Tamimi, ScD, of the Brigham and Women’s Hospital and Harvard Medical School Channing Division Of Network Medicine; Graham G. Giles, PhD, of the Cancer Epidemiology & Intelligence Division, Cancer Council Victoria, Melbourne, Australia; Inger T. Gram, MD, PhD, of the Department of Community Medicine, University of Tromsø; Susan E. Hankinson, ScD, of the Department of Biostatistics and Epidemiology at the School of Public Health and Health Sciences at the University of Massachusetts; Judy Hoffman-Bolton, AA, at the Johns Hopkins Bloomberg School of Public Health; Rudolf Kaaks, PhD, of the Division of Cancer Epidemiology in Heidelberg, Germany; Timothy J. Key, DPhil, of the University of Oxford; Cari M. Kitahara, PhD, and Martha Linet, MD, of the National Cancer Institute Division of Cancer Epidemiology and Genetics Radiation Branch; Susanna C. Larsson, PhD, at the Karolinka Institutet; Melissa A. Merritt, PhD, and Elio Riboli, MD, of the Imperial College London School of Public Health; Roger L. Milne, PhD, of Cancer Council Victoria and The University of Melbourne School of Population and Global Health Centre for Epidemiology and Biostatistics: Vaeria Pala, DrSc, of Cancer Registry Norway; Petra H. Peeters, MD, PhD, of the University Medical Center in Utrecht, Netherlands; Malin Sund, MD, PhD, of the Department of Surgical and Perioperative Sciences of Umea University, Sweden; Anne Tjønneland, MD, PhD, DMSc, of the Danish Cancer Society Research Centre, Copenhagen, Denmark; Antonia Trichopoulou, MD, PhD, of the Hellenic Health Foundation in Greece; Giske Ursin, MD, and Lars Vatten, MD, PhD, of the Norwegian University of Science and Technology; Kala Visvanathan, MD, of the Johns Hopkins Bloomberg School of Public Health and the University of Oxford; Elsabet Weiderpass, MD, PhD of the Karolinska Institute, the Arctic University of Norway, and the Folkhälsen Research Center in Helsinki Alicja Wolkd, DrMedSc of the Karolinska Institutet; and Clarice R. Weinberg, PhD, of the National Institute of Environmental Health Sciences Biostatistics and Computational Biology Branch.
The study was supported by the Avon Foundation, Breast Cancer Now, the National Institute of Environmental Health Sciences, the United Kingdom National Health Service funding to the Royal Marsden/ICR NIHR Biomedical Research Centre, The Institute of Cancer Research, London, the National Cancer Institute, the U.S. National Center for Advancing Translational Sciences, the National Program of Cancer Registries of the Centers for Disease Control and Prevention, the Department of Energy, the Swedish Research Council and Swedish Cancer Foundation, the Japanese Ministry of Health, Labour and Welfare, the Hellenic Health Foundation, Karolinska Institutet Distinguished Professor Award, Cancer Council Victoria and the Australia National Health and Medical Research Council, the state of Maryland, and the Maryland Cigarette Restitution Fund.
University of North Carolina at Chapel Hill School of Medicine